AbbVie is also trying to extend the indications for the FRα-targeting antibody-drug conjugate (ADC), with a phase 3 study on the go in platinum-sensitive ovarian cancer, and will also be tested ...

Drug A killed all the rats, mice and dogs. Drug B killed all the dogs and rats. Drug C killed all the mice and rats. Drug D was taken by all the animals up to huge doses with no ill effect.